NCT06927271

Brief Summary

The goal of this clinical trial is to find out if phone call and video-based interventions that seek to educate people with uncontrolled high blood pressure and also remind them to take their medicines will improve adherence to their medicines. It will also examine if the interventions are economical to implement. The main objectives of the study are:

  • Design videos and phone call-based interventions for people with hypertension.
  • Examine the effect of videos and phone call-based intervention on adherence to medication in people with hypertension.
  • Calculate the costs associated with the mobile health intervention
  • Examine the factors influencing acceptance of video and phone calls based interventions for improving adherence to antihypertensive medications among patients Participants will:
  • Receive the intervention thrice weekly for 3 months
  • Visit the health facility at the end of 3 months for check up and measurement of outcome variables (adherence and blood pressure). Additionally, at the end of 3 months, the acceptability of the interventions will be measured among the participants who received either phone call or video. Researchers will compare the two groups (one group will utilize phone call whereas the other videos) with the control group to see if the mobile interventions improve adherence to medicines. Only adults 18 years and above in selected health facilities in the Eastern will participate in the study. The selected participants should have uncontrolled blood pressure based on readings from last 2 visits. To be included in the study, the participants need to own a smartphone.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,400

participants targeted

Target at P75+ for not_applicable hypertension

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 17, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

February 24, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2025

Completed
Last Updated

April 15, 2025

Status Verified

February 1, 2025

Enrollment Period

6 months

First QC Date

January 17, 2025

Last Update Submit

April 13, 2025

Conditions

Keywords

hypertensionadherencemedicationsmHealthmobile technology

Outcome Measures

Primary Outcomes (2)

  • change in systolic blood pressure

    The systolic blood pressure at baseline will be compared to the systolic pressure at endline. This will help to determine if the intervention has an effect on the blood pressure

    baseline and 3 months

  • Medication adherence measured using the Morisky Medication Adherence Scale-8(MMAS-8)

    Medication adherence will be measured at baseline and then after administering the intervention. MMAS-8 has eight items on the scale. The first seven (7) items on the scale require a yes or no response whereas the eighth item uses a five-point Likert scale (never/rarely to all the time). The total score ranges from 0 to 8 with a score of \<6 indicative of non-adherence. A score between 6 \< 8 indicates medium adherence whereas a score of 8 shows high adherence.

    baseline and 3 months

Secondary Outcomes (2)

  • Proportion of patients with controlled blood pressure

    baseline and 3 months

  • Acceptability of the intervention

    3 months

Study Arms (3)

the video-group

ACTIVE COMPARATOR

In this arm, participants with uncontrolled blood pressure will receive videos via WhatsApp to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the video intervention in addition to usual care (which is the care they receive from health facilities)

Other: Video based intervention

the phone call group

ACTIVE COMPARATOR

In this arm, participants with uncontrolled blood pressure will receive phone calls to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the phone call intervention in addition to usual care (which is the care they receive from health facilities)

Other: phone call based intervention

control group

PLACEBO COMPARATOR

This group will neither receive phone call or videos. The group will only receive a message that indicates that they are being enrolled into the study.

Other: Usual Care

Interventions

The phone call based intervention seek to educate patients about hypertension and the medications used. It also seeks to remind patients to take their medications. This will be done thrice weekly

the phone call group

The video based intervention seek to educate patients about hypertension and the medications used. It also seeks to remind patients to take their medications. This will be done thrice weekly

the video-group

The usual care concerns the care the participants receive from the health facility. Participants in this group would neither receive the phonecall or video based interventions.

control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult aged 18 years or older
  • diagnosed of hypertension
  • has uncontrolled hypertension (i.e. systolic blood pressure ≥140 mmHg and a diastolic blood pressure ≥ 90mmHg) documented in their records on 2 clinic visits
  • has been prescribed at least one antihypertensive medication for a period of 2 months before the study
  • owns a smart phone or has access to one at all times.

You may not qualify if:

  • Pregnant women with hypertension or within 3 months postpartum
  • Hypertensive patients with diabetes, liver failure or kidney disease
  • Plans to travel out of the country during the period of the study
  • Participating in another mobile health intervention or medication adherence intervention
  • has a psychiatric disease or mental illness 6) has a visual impairment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Joseph Catholic Hospital

Efiduase, Koforidua, Ghana

RECRUITING

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Patrick Asuming, PhD

    University of Ghana

    STUDY DIRECTOR
  • Gordon Abekah-Nkrumah, PhD

    University of Ghana

    STUDY CHAIR

Central Study Contacts

Grace Okai, MPhil

CONTACT

Gordon Abekah-Nkrumah, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 17, 2025

First Posted

April 15, 2025

Study Start

February 24, 2025

Primary Completion

August 30, 2025

Study Completion

August 30, 2025

Last Updated

April 15, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

Data set or information that will be shared include study protocol

Shared Documents
STUDY PROTOCOL
Time Frame
The study protocol will be available
Access Criteria
The study protocol will be available online to all. The study protocol will be shared through publications.

Locations